Precision BioSciences

About:

Precision BioSciences is a biotechnology company dedicated to improving life.

Website: https://precisionbiosciences.com

Twitter/X: precisionbiosci

Top Investors: RA Capital Management, Alexandria Venture Investments, Gilead Sciences, F-Prime Capital, Perceptive Advisors

Description:

Precision BioSciences is a biotechnology company dedicated to improving lives through its next-generation gene editing technology, ARCUS. Precision BioSciences’ mission is to translate the world’s most powerful genome editing technology into greatly needed products throughout the life sciences. Precision’s proprietary ARCUS genome editing technology enables the production of highly specific nucleases that can insert, remove, and modify DNA at essentially any location in a complex genome.

Total Funding Amount:

$265M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Durham, North Carolina, United States

Founded Date:

2006-01-01

Contact Email:

partner(AT)precisionbiosciences.com

Founders:

Derek Jantz, Jeff Smith, Matthew Kane

Number of Employees:

101-250

Last Funding Date:

2024-03-01

IPO Status:

Public

Industries:

© 2025 bioDAO.ai